Sunday, September 12, 2010

Martek Biosciences plans appeal of E.U. ruling on infant formula patent - Baltimore Business Journal:

glafirarynyxu.blogspot.com
That was word from the Columbiz company Tuesday inregulatory filings. The patent office in the Hague, Netherlands upheld a patent that was granted to the biotech firm in 2007 but was challenged by food manufacturerxsand Ltd. The patentf office said Martek’s patent applies to Martek’ds nutritional oil in infant formula, but is not covererd when it is blended with certain fish oils used ininfant formula. Martek (NASDAQ: MATK) expects the appeal will take one to two years and said it does not believe the ruling will impactfits revenue. Derived from algae, the company’d nutritional oils are also used in dietary supplements and food such as yogurtand juice.
The compant has been aggressively expanding its infant formulwa business overseas as it has nearlt saturatedthe U.S. market. Martej warned in its last earnings statementy that its infant formula sales in the thircd and fourth quarters could drop as retailers trim their inventoriex ofthe product. The company anticipates demand will pick up infiscal 2010.

No comments:

Post a Comment